Improving patient & practice outcomes in depression care.
Do you find that many of your MDD patients fail to respond to SSRIs?
Are your patients struggling through months of failed treatments due to the educated guessing that applies to the current standard of care for MDD?
Read our white paper to learn about MindLight Antidepressant Response Test™, the first truly predictive antidepressant response test based on circular RNA biomarkers. MindLight™ analyzes a brain-derived circular RNA biomarker that predicts whether an adult MDD patient will respond to SSRI therapy. The MindLight test predicts SSRI response with high accuracy, and this precision test will streamline the treatment process for your MDD patients.